精神疾病,抗抑郁药和心血管疾病之间的双向关联
Hongbao Cao1, Ancha Baranova1,2, Qian Zhao3
1School of Systems Biology, George Mason University, Fairfax, Virginia, USA.
BMJ mental health
|March 15, 2024
概括
精神障碍如严重抑郁症 (MDD),多动症 (ADHD) 和失眠等精神障碍会增加心血管疾病 (CVD) 的风险. 抗抑郁药的使用是一个独立的心血管疾病风险因素,它调解了MDD和心血管疾病之间的联系.
科学领域:
- 精神病学和心脏病学
- 遗传流行病学遗传流行病学
- 药物监督 药物监督 药物监督
背景情况:
- 精神疾病和心血管疾病 (CVD) 经常同时发生,但它们的因果关系尚未完全理解.
- 心理健康状况和心血管疾病之间的双向因果关系需要进行系统的调查.
研究的目的:
- 系统地探索主要精神障碍和心血管疾病之间的双向因果关系.
- 调查抗抑郁药使用作为精神疾病和心血管疾病之间关系的潜在调解者的作用.
主要方法:
- 使用孟德尔随机化 (MR) 和多变量MR (MVMR) 分析.
- 研究了10种精神障碍,抗抑郁药的使用和7种特定心血管疾病之间的潜在因果关系.
- 评估了心理健康状况和心血管结果之间的双向因果关系.
主要成果:
- 重度抑郁症 (MDD),注意力缺陷/多动症障碍 (ADHD) 和失眠与多重心血管疾病的风险增加有关.
- 抗抑郁药的使用成为所有研究的心血管疾病的独立风险因素,包括心律不整,心房动,冠状动脉疾病,高血压,心力衰竭和中风.
- 虽然MDD,ADHD和失眠与心血管疾病有关,但在本次分析中,MDD本身与心血管疾病风险增加没有直接关联.
- 心血管疾病与使用抗抑郁药物的可能性更高相关.
结论:
- 抑郁症,多动症和失眠是发展心血管疾病的潜在危险因素.
- 抗抑郁药的使用被确定为心血管疾病的独立风险因素,可能会调解MDD对心血管健康的影响.
- 在患者治疗期间,临床考虑抗抑郁药的有益和有害影响至关重要.
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
30
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
30
Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
Stress and Mental Health
156
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
156
Depressive Disorders: Etiology
85
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
85
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
384
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
384
Antidepressant Drugs: Overview
477
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
477


